Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.68 HKD
3.76 B HKD
18.82 B HKD
3.50 B
About WUXI BIOLOGICS (CAYMAN) INC
Sector
Industry
CEO
Zhi Sheng Chen
Website
Headquarters
Wuxi
Founded
2014
FIGI
BBG00GTY47H0
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2269 is 17.72 HKD — it has decreased by −0.69% in the past 24 hours. Watch WUXI BIOLOGICS (CAYMAN) INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange WUXI BIOLOGICS (CAYMAN) INC stocks are traded under the ticker 2269.
2269 stock has risen by 2.00% compared to the previous week, the month change is a 20.58% rise, over the last year WUXI BIOLOGICS (CAYMAN) INC has showed a −38.69% decrease.
We've gathered analysts' opinions on WUXI BIOLOGICS (CAYMAN) INC future price: according to them, 2269 price has a max estimate of 34.18 HKD and a min estimate of 11.91 HKD. Watch 2269 chart and read a more detailed WUXI BIOLOGICS (CAYMAN) INC stock forecast: see what analysts think of WUXI BIOLOGICS (CAYMAN) INC and suggest that you do with its stocks.
2269 reached its all-time high on Jul 2, 2021 with the price of 148.00 HKD, and its all-time low was 8.34 HKD and was reached on Jun 13, 2017. View more price dynamics on 2269 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2269 stock is 4.17% volatile and has beta coefficient of 1.74. Track WUXI BIOLOGICS (CAYMAN) INC stock price on the chart and check out the list of the most volatile stocks — is WUXI BIOLOGICS (CAYMAN) INC there?
Today WUXI BIOLOGICS (CAYMAN) INC has the market capitalization of 71.19 B, it has increased by 0.92% over the last week.
Yes, you can track WUXI BIOLOGICS (CAYMAN) INC financials in yearly and quarterly reports right on TradingView.
WUXI BIOLOGICS (CAYMAN) INC is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
2269 earnings for the last half-year are 0.38 HKD per share, whereas the estimation was 0.44 HKD, resulting in a −14.63% surprise. The estimated earnings for the next half-year are 0.46 HKD per share. See more details about WUXI BIOLOGICS (CAYMAN) INC earnings.
WUXI BIOLOGICS (CAYMAN) INC revenue for the last half-year amounts to 9.21 B HKD, despite the estimated figure of 8.98 B HKD. In the next half-year revenue is expected to reach 10.13 B HKD.
2269 net income for the last half-year is 1.62 B HKD, while the previous report showed 1.22 B HKD of net income which accounts for 32.71% change. Track more WUXI BIOLOGICS (CAYMAN) INC financial stats to get the full picture.
No, 2269 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 12.74 K employees. See our rating of the largest employees — is WUXI BIOLOGICS (CAYMAN) INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WUXI BIOLOGICS (CAYMAN) INC EBITDA is 5.36 B HKD, and current EBITDA margin is 31.22%. See more stats in WUXI BIOLOGICS (CAYMAN) INC financial statements.
Like other stocks, 2269 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WUXI BIOLOGICS (CAYMAN) INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WUXI BIOLOGICS (CAYMAN) INC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WUXI BIOLOGICS (CAYMAN) INC stock shows the sell signal. See more of WUXI BIOLOGICS (CAYMAN) INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.